| abstract |
The present invention relates to certain bicyclic bis-heteroaryl compounds of formula (I), pharmaceutical compositions containing them and methods of using them, including methods of preventing, reversing, delaying or inhibiting protein aggregation and methods of treating diseases associated with protein aggregation, including neurodegenerative diseases such as parkinson's disease, alzheimer's disease, lewy body disease, parkinson's disease dementia, frontotemporal dementia, huntington's disease, amyotrophic lateral sclerosis and multiple system atrophy, and cancer including melanoma. |